These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Combination treatment for chronic HCV hepatitis in lymphangioleiomyomatosis: first case report. Bartalesi F; Camiciottoli G; Corti G; Maluccio NM; Biliotti E; Bartoloni A; Taliani G J Chemother; 2009 Feb; 21(1):110-1. PubMed ID: 19297285 [No Abstract] [Full Text] [Related]
25. [Hepatitis C: 15 years of life]. Perez V Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S9-10. PubMed ID: 20214283 [No Abstract] [Full Text] [Related]
26. [Hepatitis C infection. Overweight virus carriers are more difficult to cure]. MMW Fortschr Med; 2004 Mar; 146(13):58. PubMed ID: 15219135 [No Abstract] [Full Text] [Related]
27. [Treatment of elderly patients with chronic hepatitis C]. Ikeda F; Yamamoto K; Iwasaki Y Nihon Rinsho; 2011 May; 69 Suppl 4():221-6. PubMed ID: 22096923 [No Abstract] [Full Text] [Related]
28. [Anti-viral therapy of type C chronic hepatitis. 3. New development in anti-viral therapy of type C chronic hepatitis--Peg-IFN/ribavirin combination therapy and a new anti-viral treatment]. Hiramatsu N Nihon Naika Gakkai Zasshi; 2008 Jan; 97(1):75-81. PubMed ID: 18360974 [No Abstract] [Full Text] [Related]
29. [Healing of chronic hepatitis C following 12 weeks of therapy with peginterferon-alpha and ribavirin]. Barreales M; Castellano G; Fernández I; Muñoz R; Manzano M; Solís Herruzo JA Rev Esp Enferm Dig; 2007 Dec; 99(12):738-40. PubMed ID: 18290706 [No Abstract] [Full Text] [Related]
31. Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: a report of 9 cases. Buti M; Valdés A; Sánchez-Avila F; Esteban R; Lurie Y Hepatology; 2003 May; 37(5):1226-7. PubMed ID: 12717407 [No Abstract] [Full Text] [Related]